Fen Lan
Impact in
-
- Antimicrobial Peptides and Activities
-
- IL-33, ST2, and ILC Pathways
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Immune Response and Inflammation 3
- Galectins and Cancer Biology 2
- Co-authors
- Huahao Shen (8 shared papers)Shaobin Wang (2 shared papers)Weining Xiong (5 shared papers)Wen Li (6 shared papers)Zhihua Chen (5 shared papers)Yang Xia (1 shared paper)Xiaoxia Lü (4 shared papers)Guopeng Xu (4 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Food Research International (1 paper)Recent Patents on Anti-Cancer Drug Discovery (1 paper)European Respiratory Journal (1 paper)COPD Journal of Chronic Obstructive Pulmonary Disease (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Fen Lan
34 papers receiving 384 citations
Peers
Comparison fields: 5 of 89
- Microbiology 4
- Immunology 98
- Microbiology 26
- Internal Medicine 15
- Cancer Research 50
Countries citing papers authored by Fen Lan
This map shows the geographic impact of Fen Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Lan more than expected).
Fields of papers citing papers by Fen Lan
This network shows the impact of papers produced by Fen Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Lan. The network helps show where Fen Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Fen Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 42 | |
| 2 | 2020 | 38 | |
| 3 | 2021 | 33 | |
| 4 | 2010 | 32 | |
| 5 | 2016 | 31 | |
| 6 | 2018 | 25 | |
| 7 | 2014 | 20 | |
| 8 | 2018 | 20 | |
| 9 | 2016 | 14 | |
| 10 | 2010 | 12 | |
| 11 | 2009 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2021 | 10 | |
| 14 | 2012 | 10 | |
| 15 | 2014 | 10 | |
| 16 | 2010 | 10 | |
| 17 | The role of endotoxin in the pathogenesis of experimental multiple system organ failure: a preliminary report. | 1992 | 7 |
| 18 | 2015 | 6 | |
| 19 | 2022 | 6 | |
| 20 | 2019 | 6 |
About Fen Lan
Fen Lan is a scholar working on Molecular Biology, Immunology, Oncology, Pulmonary and Respiratory Medicine and Physiology, having authored 36 papers that have together received 394 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Eosinophilic Disorders and Syndromes (3 papers), Immune Response and Inflammation (3 papers), Lung Cancer Research Studies (3 papers), Galectins and Cancer Biology (2 papers), Natural product bioactivities and synthesis (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Microbiology (4 citations), Immunology (98 citations), Microbiology (26 citations), Internal Medicine (15 citations) and Cancer Research (50 citations). Fen Lan has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huahao Shen, Shaobin Wang, Weining Xiong, Wen Li, Zhihua Chen, Yang Xia, Xiaoxia Lü, Guopeng Xu, Peng Zuo and Chao Cao. Their work appears in journals such as Frontiers in Oncology, Food Research International, Recent Patents on Anti-Cancer Drug Discovery, European Respiratory Journal and COPD Journal of Chronic Obstructive Pulmonary Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.